Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001896652 | SCV002177115 | likely benign | Nemaline myopathy 2 | 2023-06-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003130588 | SCV003811538 | uncertain significance | not provided | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004041743 | SCV004980079 | uncertain significance | Inborn genetic diseases | 2024-02-12 | criteria provided, single submitter | clinical testing | The c.1512A>T (p.Q504H) alteration is located in exon 17 (coding exon 15) of the NEB gene. This alteration results from a A to T substitution at nucleotide position 1512, causing the glutamine (Q) at amino acid position 504 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |